Concepedia

Publication | Open Access

PTEN activity could be a predictive marker of trastuzumab efficacy in the treatment of ErbB2-overexpressing breast cancer

DOIFull Paper Access

156

Citations

25

References

2006

Year

Takeo Fujita, Hiroyoshi Doihara, Kaoru Kawasaki, Daisuke Takabatake, H. Takahashi, Kana Washio, Kazunori Tsukuda, Yuki Ogasawara, Nobutaka Shimizu
British Journal of Cancer

References

YearCitations

Page 1